1.Intersectin 1: a molecular linker in the central nervous system.
Ning MA ; Rui-Fang NIU ; Yong-Jie MA
Neuroscience Bulletin 2008;24(6):401-405
Down syndrome (DS) is the most common cause of cognitive impairment associated with a congenital chromosomal abnormality, trisomy of chromosome 21. Mental retardation and congenital heart defects are key features of DS. All DS individuals develop early-onset Alzheimer's disease-like neuropathology. Intersectin 1 gene is localized on human chromosome 21, the critical region of DS, and it has higher expression in the brain of DS patients than in normal individuals. So fully understanding functions of intersectin 1 is critical for revealing the pathogenesis of DS. Intersectin 1 protein has two isoforms: intersectin 1-L and intersectin 1-S. This review will focus on the distribution, expression characters and functions of intersectin 1 in the central nervous system.
Adaptor Proteins, Vesicular Transport
;
genetics
;
metabolism
;
Animals
;
Central Nervous System
;
cytology
;
metabolism
;
Chromosomes, Human, Pair 21
;
Humans
;
Mental Disorders
;
genetics
;
metabolism
;
Neurons
;
metabolism
2.Cardamine komarovii flower extract reduces lipopolysaccharide-induced acute lung injury by inhibiting MyD88/TRIF signaling pathways.
Qi CHEN ; Ke-Xin ZHANG ; Tai-Yuan LI ; Xuan-Mei PIAO ; Mei-Lan LIAN ; Ren-Bo AN ; Jun JIANG
Chinese Journal of Natural Medicines (English Ed.) 2019;17(6):461-468
In the present study, we investigated anti-inflammatory effect of Cardamine komarovii flower (CKF) on lipopolysaccharide (LPS)-induced acute lung injury (ALI). We determined the effect of CKF methanolic extracts on LPS-induced pro-inflammatory mediators NO and prostaglandin E2 (PGE2), production of pro-inflammatory cytokines (IL-1β, TNF-α, and IL-6), and related protein expression levels of MyD88/TRIF signaling pathways in peritoneal macrophages (PMs). Nuclear translocation of NF-κB-p65 was analyzed by immunofluorescence. For the in vivo experiments, an ALI model was established to detect the number of inflammatory cells and inflammatory factors (IL-1β, TNF-α, and IL-6) in bronchoalveolar lavage fluid (BALF) of mice. The pathological damage in lung tissues was evaluated through H&E staining. Our results showed that CKF can decrease the production of inflammatory mediators, such as NO and PGE2, by inhibiting their synthesis-related enzymes iNOS and COX-2 in LPS-induced PMs. In addition, CKF can downregulate the mRNA levels of IL-1β, TNF-α, and IL-6 to inhibit the production of inflammatory factors. Mechanism studies indicated that CKF possesses a fine anti-inflammatory effect by regulating MyD88/TRIF dependent signaling pathways. Immunocytochemistry staining showed that the CKF extract attenuates the LPS-induced translocation of NF-kB p65 subunit in the nucleus from the cytoplasm. In vivo experiments revealed that the number of inflammatory cells and IL-1β in BALF of mice decrease after CKF treatment. Histopathological observation of lung tissues showed that CKF can remarkably improve alveolar clearance and infiltration of interstitial and alveolar cells after LPS stimulation. In conclusion, our results suggest that CKF inhibits LPS-induced inflammatory response by inhibiting the MyD88/TRIF signaling pathways, thereby protecting mice from LPS-induced ALI.
Acute Lung Injury
;
chemically induced
;
drug therapy
;
genetics
;
metabolism
;
Adaptor Proteins, Vesicular Transport
;
genetics
;
metabolism
;
Animals
;
Anti-Inflammatory Agents
;
administration & dosage
;
chemistry
;
Cardamine
;
chemistry
;
Cyclooxygenase 2
;
genetics
;
metabolism
;
Female
;
Flowers
;
chemistry
;
Humans
;
Lipopolysaccharides
;
adverse effects
;
Male
;
Mice
;
Myeloid Differentiation Factor 88
;
genetics
;
metabolism
;
NF-kappa B
;
genetics
;
metabolism
;
Nitric Oxide Synthase Type II
;
genetics
;
metabolism
;
Plant Extracts
;
administration & dosage
;
chemistry
;
Signal Transduction
;
drug effects
;
Tumor Necrosis Factor-alpha
;
genetics
;
metabolism
3.Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts.
Mi Kyung PARK ; Hye Jwa OH ; Yang Mi HEO ; Eun Mi PARK ; Mi La CHO ; Ho Youn KIM ; Sung Hwan PARK
Experimental & Molecular Medicine 2011;43(8):446-454
Indoleamine 2,3-dioxygenase (IDO) is a key negative regulator of immune responses and has been implicated in tumor tolerance, autoimmune disease and asthma. IDO was detected in the joint synovial tissue in the inflammatory microenvironment of rheumatoid arthritis (RA), but IDO expression in joint synovial tissue is not sufficient to overcome the inflamed synovial environment. This study aimed to unravel the mechanisms involving the failure to activate tolerogenic IDO in the inflamed joint. We demonstrate that both poly (I:C) and lipopolysaccharide (LPS) induce expression of IDO in synovial fibroblasts. However, inflammatory cytokines such as IL-17, TNF-alpha, IL-12, IL-23 and IL-16 did not induce IDO expression. Poly (I:C) appeared to induce higher IDO expression than did LPS. Surprisingly, toll-like receptor (TLR)4-mediated IDO expression was upregulated after depletion of myeloid differentiation primary response protein 88 (MyD88) in synovial fibroblasts using small interfering RNA (siRNA). IDO, TLR3 and TLR4 were highly expressed in synovial tissue of RA patients compared with that of osteoarthritis patients. In addition, RA patients with severe disease activity had higher levels of expression of IDO, TLR3 and TLR4 in the synovium than patients with mild disease activity. These data suggest that upregulation of IDO expression in synovial fibroblasts involves TLR3 and TLR4 activation by microbial constituents. We showed that the mechanisms responsible for IDO regulation primarily involve MyD88 signaling in synovial fibroblasts, as demonstrated by siRNA-mediated knockdown of MyD88.
Adaptor Proteins, Vesicular Transport/genetics/metabolism
;
Arthritis, Rheumatoid/*metabolism
;
Blotting, Western
;
Cells, Cultured
;
Fibroblasts/drug effects/*metabolism
;
Humans
;
Immunohistochemistry
;
Indoleamine-Pyrrole 2,3,-Dioxygenase/genetics/*metabolism
;
Interleukin-12/pharmacology
;
Interleukin-16/pharmacology
;
Interleukin-17/pharmacology
;
Interleukin-23/pharmacology
;
Lipopolysaccharides/pharmacology
;
Myeloid Differentiation Factor 88/genetics/*metabolism
;
Poly I-C/pharmacology
;
Polymerase Chain Reaction
;
RNA, Small Interfering/genetics/physiology
;
Synovial Membrane/*cytology
;
Toll-Like Receptor 4/genetics/metabolism
;
Tumor Necrosis Factor-alpha/pharmacology
4.Effect of Shensu Yin on the expression of toll-like receptors and the downstream signaling components on RAW 264.7 cells.
Bao-Sheng ZHAO ; Lan-Fang LI ; Yue-Ying MA ; Shu-Ying GUO ; Cang-Hai LI ; Hai-Ru HUO ; Ting-Liang JIANG
China Journal of Chinese Materia Medica 2007;32(4):327-332
OBJECTIVETo investigate the influences of Shensu Yin to RAW 264.7 on the expression of TLR3, TLR4 and the factors of the downstream in RAW 264. 7 cells.
METHODRAW 264.7 cell line was stimulated with Lipopolysaccharide and POLY I: C, respectively, and treated with the drug serum of Shensuyin simultaneously. 24 hours later, collected the supernatant and measured the inflammatory factors TNF-alpha and IFN-beta, extracted mRNA and measured the expression of TLR3, TLR4 and other correlated indexes of the downstream, analyzed and evaluated Shensu Yin's substance basis of pharmacodynamic actions.
RESULTShensu Yin drug serum depressed the expression of TLR4, MyD88, TRAF-6, TRAM and TRIF mRNA, as a result, it decreased the amount of TNF-alpha and IFN-beta.
CONCLUSIONDepressing the expression of TLR3, MyD88, TRAM and TRIF mRNA may be the elementary basis of Shensu Yin to play heat-clearing and detoxicating effect.
Adaptor Proteins, Vesicular Transport ; genetics ; Animals ; Cell Line ; Drug Combinations ; Drugs, Chinese Herbal ; isolation & purification ; pharmacology ; Interferon-beta ; secretion ; Lipopolysaccharides ; pharmacology ; Macrophages ; cytology ; drug effects ; metabolism ; Male ; Mice ; Myeloid Differentiation Factor 88 ; genetics ; Plants, Medicinal ; chemistry ; Poly I-C ; pharmacology ; RNA, Messenger ; biosynthesis ; genetics ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptors, Interleukin ; genetics ; Signal Transduction ; drug effects ; Toll-Like Receptor 3 ; genetics ; Toll-Like Receptor 4 ; genetics ; Tumor Necrosis Factor-alpha ; secretion